Syphilis: Clinical Trials

16 trials for Syphilis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting, 3 unknown, 2 terminated. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 6, Recruiting 3, Unknown 3, Terminated 2, Active not recruiting 1, Not yet recruiting 1

Follow Syphilis: new trials by email Literature Review of Syphilis trials Research Report on Syphilis

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates
Benzathine Penicillin, Amoxicillin - Syphilis, Congenital
Phase 4Not yet recruitingUniversity of Alabama at Birmingham3742026-11-012026-09-02
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Doxycycline hyclate delayed released 200 mg, Doxycycline hyclate delayed released 200 mg weekly, Per standard of care with quarterly STI testing/treatment and sexual health counseling - Gonorrhea, Chlamydia
Phase 4RecruitingWestat7602026-02-272026-10-16
Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM
WHO-recommended periodic presumptive treatment, Doxycycline post-exposure prophylaxis - Gonorrhea Male, Chlamydia (Male)
Phase 4RecruitingUniversity of Washington29002025-10-292025-11-19
The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.
Doxycycline (200mg/day) - Syphilis Infection, Gonorrhea
Phase 4RecruitingBangrak STIs Center4002025-10-062026-02-09
Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM
DoxyODPrEP, DoxyPEP - Sexually Transmitted Diseases, Bacterial, Syphilis
Phase 4Active not recruitingChinese University of Hong Kong3002025-03-292026-06-05
Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline
Doxycycline, Ceftriaxone, benzathine penicillin G - Early Syphilis
Phase 4TerminatedNational Taiwan University Hospital1092023-03-102026-02-25
Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis
Cefixime 400mg, Benzathine penicillin 2.4 million units - Syphilis
Phase 4TerminatedBulovka Hospital612021-07-132025-04-02
Syphilis Self-testing to Expand Test Uptake Among Men Who Have Sex With Men (SST)
Access to Facility based Syphilis Testing, Syphilis Self-Test - Syphilis
Phase 4CompletedLondon School of Hygiene and Tropical Medicine1002020-10-142022-07-25
Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
Doxycycline Hyclate Delayed-Release 200 mg - Gonorrhea, Chlamydia
Phase 4CompletedUniversity of California, San Francisco6412019-11-262024-07-12
Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex with Men (DaDHS)
Doxycycline, Placebo - Syphilis, Sexually Transmitted Infections
Phase 4CompletedBritish Columbia Centre for Disease Control522019-08-152025-02-12
Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection
Benzathine Penicillin - Syphilis
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2492018-10-312025-01-14
Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM
Doxycycline 100mg PO daily x 12 months, Tenofovir/emtricitabine 200/300mg PO daily, Doxycycline 100mg PO daily x 6 months - HIV, Syphilis
Phase 4CompletedBritish Columbia Centre for Disease Control522018-05-152024-08-02
The Association Between Molecular Typing of Treponema Pallidum and Treatment Efficacy and Clinical Findings
Benzathine Penicillin G - Syphilis
Phase 4UnknownPeking Union Medical College Hospital1502016-08-012018-11-16
One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis
Benzathine Penicillin G - Syphilis
Phase 4UnknownJun Li1502016-08-012018-11-16
Serological Response to Retreatment of Serofast Early Syphilis Cases With Benzathine Penicillin
benzathine penicillin - Syphilis
Phase 4UnknownPeking Union Medical College Hospital1502016-08-012018-11-16
Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study
Benzathine penicillin G intramuscular 7.2 million units, Benzathine penicillin G intramuscular 2.4 million units - Syphilis
Phase 4CompletedBaylor College of Medicine642008-09-012016-05-17

Narrower conditions

Chlamydia Infections (6)  ·  Gonorrhea (6)  ·  Sexually Transmitted Diseases (6)  ·  Homosexuality (4)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Sexually Transmitted Diseases, Bacterial (1)  ·  Syphilis, Congenital (1)  ·  Treponemal Infections (1)

Broader conditions

Bacterial Infections (16)  ·  Bacterial Infections and Mycoses (16)  ·  Gram-Negative Bacterial Infections (16)  ·  Infections (16)  ·  Spirochaetales Infections (16)  ·  Communicable Diseases (15)  ·  Genital Diseases (15)  ·  Treponemal Infections (15)  ·  Urogenital Diseases (15)  ·  Sexually Transmitted Diseases, Bacterial (14)  ·  Sexually Transmitted Diseases (9)  ·  Chlamydiaceae Infections (6)  ·  Disease Attributes (6)  ·  Neisseriaceae Infections (6)  ·  Pathologic Processes (6)

Interventions

Doxycycline (4)  ·  Penicillin G (3)  ·  Penicillin G Benzathine (3)  ·  Amoxicillin (1)  ·  Cefixime (1)  ·  Ceftriaxone (1)  ·  Emtricitabine (1)  ·  Standard of Care (1)  ·  Tenofovir (1)  ·  Therapeutics (1)

Sponsors

British Columbia Centre for Disease Control (2)  ·  Peking Union Medical College Hospital (2)  ·  Bangrak STIs Center (1)  ·  Baylor College of Medicine (1)  ·  Bulovka Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Jun Li (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Taiwan University Hospital (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, San Francisco (1)  ·  University of Washington (1)  ·  Westat (1)

Countries

United States (4)  ·  China (3)  ·  Canada (2)  ·  Czechia (1)  ·  Hong Kong (1)  ·  Kenya (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  Zimbabwe (1)

Top investigators

Troy Grennan, MD (2)  ·  Anne Luetkemeyer, MD (1)  ·  Cherie Blaire, MD, PhD (1)  ·  David Kimberlin, MD (1)  ·  Jenell Stewart, DO, MPH (1)  ·  Jodie Dionne, MD (1)  ·  Jose A Serpa-Alvarez, MD (1)  ·  Kuan-Yin Lin (1)  ·  Susan M Graham, MD, PhD, MPH (1)  ·  Tsz Ho Kwan, PhD (1)

Results publications

PMID 37018493, PMID 25585069, PMID 25870333, PMID 28200045, PMID 29229440, PMID 33835852, PMID 34143341, PMID 34392717, PMID 34852691, PMID 35067599, PMID 38118022, PMID 38124508, PMID 38656217, PMID 38797183, PMID 39363100, PMID 39946129, PMID 40147465, PMID 40637301, PMID 40902161, PMID 41494183, PMID 41873979

NIH funding

R01AI143439 (1), R01AI179838 (1), UM2HD111076 (1), UM2HD111102 (1)